10x Genomics to Present at the BofA Securities 2023 Healthcare Conference

Rhea-AI Summary

10x Genomics, a leader in life sciences, announced its participation in a fireside chat at the BofA Securities 2023 Healthcare Conference on May 10, 2023, at 2:20 p.m. Pacific Time. The event will focus on advancing human health through innovative biological solutions.

Investors can access a live webcast of the chat via the company's website, with an archive available for replay for at least 45 days. 10x Genomics specializes in integrated solutions that include instruments, consumables, and software for biological analysis. The company has a strong presence in top research institutions and pharmaceutical companies, cited in over 4,500 research papers.

PLEASANTON, Calif., April 25, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, at 2:20 p.m. Pacific Time.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event. 

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2021 based on publications and all of the top 20 global pharmaceutical companies by 2021 research and development spend and have been cited in over 4,500 research papers on discoveries ranging from oncology to immunology and neuroscience. Our patent portfolio comprises more than 1,750 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-bofa-securities-2023-healthcare-conference-301807438.html

SOURCE 10x Genomics, Inc.

FAQ

What is the date and time of the 10x Genomics fireside chat?

The 10x Genomics fireside chat is scheduled for May 10, 2023, at 2:20 p.m. Pacific Time.

Where can I watch the 10x Genomics webcast?

The webcast can be accessed on the Investors section of the 10x Genomics website at https://investors.10xgenomics.com/.

What is 10x Genomics known for?

10x Genomics is known for providing advanced life science technology for biological analysis, with products used globally in top research institutions and pharmaceutical companies.

How many patents does 10x Genomics hold?

10x Genomics has more than 1,750 issued patents and patent applications.

How has 10x Genomics impacted research?

10x Genomics products have been cited in over 4,500 research papers across various fields, including oncology and immunology.